Abstract:Background: Clear cell renal cell carcinoma (ccRCC) represents approximately 70% of RCC,as the most frequent histological subtype of RCC. MiR-138-5p, a tumor-related microRNA (miRNA), has been reported to be implicated in the diverse types of human malignancies. but its role in ccRCCremains unclear. Objective: The study was designed to investigate the functional behaviors and regulatory mechanisms of miR-138-5p in ccRCC. Materials and Methods: Quantitative real-time PCR and western blotting analyses were performed to determine the expression of miR-138-5p and Transmembrane protein 40 (TMEM40) in ccRCC tissues. Pearson's correlation coefficient was utilized to evaluate the correlation between miR-138-5p and TMEM40 expression. The function of miR-138-5p and TMEM-10 in the cell proliferation, migration and invasion of ccRCC cells (786-O and ACHN) was assessed by Cell Counting Kit-8, colony formation, wound healing and transwell assay, respectively. A luciferase reporter assay was performed to confirm the direct binding of miR-138-5p to the target gene TMEM40. Results: We found the expression of miR-138-5p was significantly down-regulated, while TMEM40 was remarkably upregulated in ccRCC tissues. TMEM40 expression was discovered to be inversely correlated with miR-138-5p expression in ccRCC tissues. Functional studies demonstrated that ntiR-138-5p overexpression or TMEM40 knockdown significantly suppressed ccRCC cell proliferation, migration and invasion in vitro. Notably, we experimentally confirmed that miR-138-5p directly recognizes the 3'-UTR of the TMEM40 transcript and down-regulated its expression in ccRCC cells. Conclusions: Taken together, our findings provide the first clues regarding the role of miR-138-5p as a tumor suppressor in ccRCC by directly targeting of TMEM40.

Mir-125B is Associated with Renal Cell Carcinoma Cell Migration, Invasion and Apoptosis

Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.

Identification of Mir-195-3p As an Oncogene in RCC

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

Mir-625-3p Promotes Migration and Invasion and Reduces Apoptosis of Clear Cell Renal Cell Carcinoma.

Oncogenic Mir-425-5p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Tumor Mir-125B Predicts Recurrence and Survival of Patients with Clear-Cell Renal Cell Carcinoma after Surgical Resection

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

Tumor Suppressor Mir-149-5p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma.

Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-Oncogene in Human Invasive Breast Cancer.

Oncogenic Mir-100-5p is Associated with Cellular Viability, Migration and Apoptosis in Renal Cell Carcinoma.

Oncogenic Microrna-142-3p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma.

Tumor Suppressive Mir-196A is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Data from Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer

Identification of Mir-130B As an Oncogene in Renal Cell Carcinoma

Microrna-191-5p Exerts A Tumor Suppressive Role In Renal Cell Carcinoma

Mir-125B Promotes Colorectal Cancer Migration and Invasion by Dual-Targeting CFTR and CGN

MicroRNA-125b may function as an oncogene in lung cancer cells.

Downregulation of Transmembrane Protein 40 by Mir-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.

Oncogenic microRNA-1423 p is associated with cellular migration , proliferation and apoptosis in renal cell carcinoma

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf